- Conditions
- Hemophilia A
- Interventions
- ReFacto AF, B-Domain deleted Recombinant Factor VIII, BDDrFVIII
- Genetic
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 12 Years and older · Male only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 21
- States / cities
- Phoenix, Arizona • Sacramento, California • San Diego, California + 18 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Hemophilia A
- Interventions
- ReFacto
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 6 Years and older · Male only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 4
- States / cities
- Los Angeles, California • New Brunswick, New Jersey • Cincinnati, Ohio + 1 more
- Conditions
- Hemophilia A
- Interventions
- ReFacto AF
- Biological
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 12 Years and older · Male only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 8
- States / cities
- La Jolla, California • Detroit, Michigan • Chapel Hill, North Carolina + 4 more
- Conditions
- Hemophilia A
- Interventions
- Moroctocog alfa(AF-CC), Blood draw for laboratory testing
- Biological · Procedure
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 12 Years and older · Male only
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 5
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Detroit, Michigan + 2 more
- Conditions
- Hemophilia A
- Interventions
- Moroctocog alfa (AF-CC)
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 6 Months to 15 Years · Male only
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2018
- U.S. locations
- 7
- States / cities
- Cincinnati, Ohio • Portland, Oregon • Dallas, Texas + 1 more
- Conditions
- Hemophilia A
- Interventions
- GreenGene™ F and an approved recombinant Factor VIII product, GreenGene™ F
- Biological
- Lead sponsor
- Green Cross Corporation
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 10
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Torrance, California + 7 more
- Conditions
- Hemophilia A
- Interventions
- ReFacto, Advante
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 18 Years to 64 Years · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005
- U.S. locations
- 4
- States / cities
- Washington D.C., District of Columbia • Atlanta, Georgia • Iowa City, Iowa + 1 more